Articles

A three-state language competition model including language learning and attrition

in Multi- and Cross-Disciplinary Complexity

• Stefano Scialla
• Jens-Kristjan Liivand
• Marco Patriarca
• Els Heinsalu

Data-Driven Reliability Evaluation of the Integrated Energy System Considering Optimal Service Restoration

in Smart Grids

• Pan Dai
• Li Yang
• Yang Zeng
• Ming Niu
• Chao Zhu
• Zhesheng Hu
• Yuheng Zhao

Combining Coarse-Grained Simulations and Single Molecule Analysis Reveals a Three-State Folding Model of the Guanidine-II Riboswitch

in Structural Biology

• Christin Fuks
• Sebastian Falkner
• Nadine Schwierz
• Martin Hengesbach

Kinetic Modeling of the Arabidopsis Cryptochrome Photocycle: FADHo Accumulation Correlates with Biological Activity

in Plant Cell Biology

• Maria Procopio
• Justin Link
• Dorothy Engle
• Jacques Witczak
• Thorsten Ritz
• Margaret Ahmad

High frequency stimulation activates hot spots of spontaneous synaptic transmission

• Herson Astacio
• Maria Bykhovskaia

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States

in Drugs Outcomes Research and Policies

• Gengwei Huo
• Ying Song
• Wenjie Liu
• Xuchen Cao
• Peng Chen

Theories and Methods for Labeling Cognitive Workload: Classification and Transfer Learning

in Cognitive Neuroscience

• Ryan McKendrick
• Bradley Feest
• Amanda Harwood
• Brian Falcone

Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in China

in Thoracic Oncology

• Hao Wang
• Li Liao
• Yuan Xu
• Yunchun Long
• Ye Wang
• Yujie Zhou

Highly Luminescent Nucleoside-Based N, P-Doped Carbon Dots for Sensitive Detection of Ions and Bioimaging

in Analytical Chemistry

• Mengru Wang
• Mengling Liu
• Shuli Nong
• Wenzhu Song
• Xianpeng Zhang
• Shuang Shen
• Guohong Jian
• Xiangyao Chen
• Zhanchao Li
• Li Xu

Cost-effectiveness analysis of sugemalimab vs. chemotherapy as first-line treatment of metastatic nonsquamous non-small cell lung cancer

in Drugs Outcomes Research and Policies

• Zhiwei Zheng
• Huide Zhu
• Ling Fang
• Hongfu Cai

Cost-Effectiveness Analysis of Adding Daratumumab to Bortezomib, Melphalan, and Prednisone for Untreated Multiple Myeloma

in Drugs Outcomes Research and Policies

• Yaohua Cao
• Lina Zhao
• Tiantian Zhang
• Weiling Cao

Multiscale and Multiphysics Modeling of Anisotropic Cardiac RFCA: Experimental-Based Model Calibration via Multi-Point Temperature Measurements

in Computational Physiology and Medicine

• Leonardo Molinari
• Martina Zaltieri
• Carlo Massaroni
• Simonetta Filippi
• Alessio Gizzi
• Emiliano Schena

Protein flexibility in the light of structural alphabets

in Structural Biology

• Pierrick Craveur
• Agnel Praveen Joseph
• Jeremy Esque
• Tarun JaiRaj Narwani
• Floriane Noel
• Nicolas Shinada
• Matthieu Goguet
• Léonard Sylvain
• Pierre Poulain
• Olivier Bertrand

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis

in Health Economics

• Mingyang Feng
• Yue Chen
• Yang Yang
• Qiu Li

The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China

in Health Economics

• Rui Meng
• Yingdan Cao
• Ting Zhou
• Hongfei Hu
• Yijin Qiu

Cost-effectiveness analysis of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China

in Cancer Immunity and Immunotherapy

• Zhengxiong Li
• Jing He
• Kai Ma